Medikaloka Hermina (Indonesia) Market Value
HEAL Stock | IDR 1,300 10.00 0.78% |
Symbol | Medikaloka |
Medikaloka Hermina 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medikaloka Hermina's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medikaloka Hermina.
12/16/2024 |
| 03/16/2025 |
If you would invest 0.00 in Medikaloka Hermina on December 16, 2024 and sell it all today you would earn a total of 0.00 from holding Medikaloka Hermina PT or generate 0.0% return on investment in Medikaloka Hermina over 90 days. Medikaloka Hermina is related to or competes with Mitra Keluarga, Siloam International, Prodia Widyahusada, Sumber Alfaria, and Elang Mahkota. PT Medikaloka Hermina Tbk operates a network of general hospitals in Indonesia More
Medikaloka Hermina Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medikaloka Hermina's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medikaloka Hermina PT upside and downside potential and time the market with a certain degree of confidence.
Information Ratio | (0.02) | |||
Maximum Drawdown | 13.65 | |||
Value At Risk | (4.60) | |||
Potential Upside | 4.38 |
Medikaloka Hermina Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medikaloka Hermina's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medikaloka Hermina's standard deviation. In reality, there are many statistical measures that can use Medikaloka Hermina historical prices to predict the future Medikaloka Hermina's volatility.Risk Adjusted Performance | (0.04) | |||
Jensen Alpha | (0.18) | |||
Total Risk Alpha | 0.16 | |||
Treynor Ratio | 0.8143 |
Medikaloka Hermina Backtested Returns
Medikaloka Hermina has Sharpe Ratio of -0.0582, which conveys that the firm had a -0.0582 % return per unit of risk over the last 3 months. Medikaloka Hermina exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Medikaloka Hermina's Risk Adjusted Performance of (0.04), standard deviation of 2.53, and Mean Deviation of 1.82 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -0.19, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Medikaloka Hermina are expected to decrease at a much lower rate. During the bear market, Medikaloka Hermina is likely to outperform the market. At this point, Medikaloka Hermina has a negative expected return of -0.15%. Please make sure to verify Medikaloka Hermina's jensen alpha, treynor ratio, and the relationship between the standard deviation and total risk alpha , to decide if Medikaloka Hermina performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.32 |
Below average predictability
Medikaloka Hermina PT has below average predictability. Overlapping area represents the amount of predictability between Medikaloka Hermina time series from 16th of December 2024 to 30th of January 2025 and 30th of January 2025 to 16th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medikaloka Hermina price movement. The serial correlation of 0.32 indicates that nearly 32.0% of current Medikaloka Hermina price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.32 | |
Spearman Rank Test | 0.28 | |
Residual Average | 0.0 | |
Price Variance | 1758.02 |
Medikaloka Hermina lagged returns against current returns
Autocorrelation, which is Medikaloka Hermina stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Medikaloka Hermina's stock expected returns. We can calculate the autocorrelation of Medikaloka Hermina returns to help us make a trade decision. For example, suppose you find that Medikaloka Hermina has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Medikaloka Hermina regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Medikaloka Hermina stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Medikaloka Hermina stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Medikaloka Hermina stock over time.
Current vs Lagged Prices |
Timeline |
Medikaloka Hermina Lagged Returns
When evaluating Medikaloka Hermina's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Medikaloka Hermina stock have on its future price. Medikaloka Hermina autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Medikaloka Hermina autocorrelation shows the relationship between Medikaloka Hermina stock current value and its past values and can show if there is a momentum factor associated with investing in Medikaloka Hermina PT.
Regressed Prices |
Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Medikaloka Stock
Medikaloka Hermina financial ratios help investors to determine whether Medikaloka Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medikaloka with respect to the benefits of owning Medikaloka Hermina security.